Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q3 2025 · 10-Q
Revenue$536.99M$536.99M−8.9% vs Q3 2024 Net Income-$3.40M-$3.40MN/M vs Q3 2024 EPS Diluted-$0.14-$0.14N/M vs Q3 2024 Gross Profit$200,881,000−1.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Operating Cash Flowderived$56,710,000+57.1% Free Cash Flowderived$27,630,000+70.7% Margins · derivedGross margin37.4%+2.6 pt vs Q3 2024
Operating margin2.6%+1.2 pt vs Q3 2024
Net margin-0.6%+5.0 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 6, 2025 · 37 d after period end